Trends in the psychopharmacological treatment of bipolar disorder: A nationwide register-based study

Acta Neuropsychiatrica

Volumn 28, Issue 2, 2016, Pages 75-84

  Bjørklund, Louise ^a   Horsdal, Henriette Thisted ^b   Mors, Ole ^a,b,c   Østergaard, Søren Dinesen ^a,b,c   Gasse, Christiane ^b  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c Aarhus   (Denmark)

Author keywords

antidepressants; bipolar disorder; mood stabilisers; psychopharmacology

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE; LITHIUM; MOOD STABILIZER; SEDATIVE AGENT; TRICYCLIC ANTIDEPRESSANT AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; BIPOLAR DISORDER; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DENMARK; DRUG USE; HUMAN; MONOTHERAPY; POLYPHARMACY; PSYCHOPHARMACOLOGY; PSYCHOPHARMACOTHERAPY; TREND STUDY; FEMALE; MALE; MIDDLE AGED; PSYCHOLOGY; REGISTER; RETROSPECTIVE STUDY; TRENDS; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIDEPRESSIVE AGENTS; BIPOLAR DISORDER; CHILD; DENMARK; DRUG THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; REGISTRIES; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84941243203     PISSN: 09242708     EISSN: 16015215     Source Type: Journal    
DOI: 10.1017/neu.2015.52     Document Type: Article

References (44)

1. VIETA E, VALENTI M. Pharmacological management of bipolar depression: acute treatment, maintenance, and prophylaxis. CNS Drugs 2013;27:515-529.
2. KUPKA RW, ALTSHULER LL, NOLEN WA et al. Three times more days depressed than manic or hypomanic in both bipolar I and bipolar II disorder. Bipolar Disord 2007;9:531-535.
3. VIKTORIN A, LICHTENSTEIN P, THASE ME et al. The risk of switch to mania in patients with bipolar disorder during treatment with an antidepressant alone and in combination with a mood stabilizer. Am J Psychiatry 2014;171:1067-1073.
4. CARLBORG A, FERNTOFT L, THURESSON M, BODEGARD J. Population study of disease burden, management, and treatment of bipolar disorder in Sweden: a retrospective observational registry study. Bipolar Disord 2015;17:76-85.
5. BAUER M, RITTER P, GRUNZE H, PFENNIG A. Treatment options for acute depression in bipolar disorder. Bipolar Disord 2012;14(Suppl. 2):37-50.
6. SIDOR MM, MACQUEEN GM. An update on antidepressant use in bipolar depression. Curr Psychiatry Rep 2012;14:696-704.
7. KESSING LV, HELLMUND G, GEDDES JR, GOODWIN GM, ANDERSEN PK. Valproate v. lithium in the treatment of bipolar disorder in clinical practice: observational nationwide register-based cohort study. Br J Psychiatry 2011;199:57-63.
8. GRUNZE H, VIETA E, GOODWIN GM et al. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar disorder. World J Biol Psychiatry 2013;14:154-219.
9. HAYES J, PRAH P, NAZARETH I et al. Prescribing trends in bipolar disorder: cohort study in the United Kingdom THIN primary care database 1995-2009. PLoS One 2011;6:e28725.
10. Sundhedsstyrelsen. Kommissorium for udarbejelse af nationale kliniske retningslinjer for medicinsk behandling af bipolar lidelse (maniodepressiv sygdom) 2013. Copenhagen (in Danish).
11. Sundhedsstyrelsen. National klinisk retningslinje for farmakologisk behandling af bipolar lidelse - supplerende vedligeholdelsesbehandling efter depression 2014. Copenhagen (in Danish).
12. GOODWIN GM. Consensus group of the British Association for Psychopharmacology. Evidence-based guidelines for treating bipolar disorder: revised second edition - recommendations from the British Association for Psychopharmacology. J Psychopharmacol 2009;23:346-388.
13. THASE ME. Bipolar depression: diagnostic and treatment considerations. Dev Psychopathol 2006;18:1213-1230.
14. PACCHIAROTTI I, BOND DJ, BALDESSARINI RJ et al. The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders. Am J Psychiatry 2013;170:1249-1262.
15. LICHT RW, GIJSMAN H, NOLEN WA, ANGST J. Are antidepressants safe in the treatment of bipolar depression? A critical evaluation of their potential risk to induce switch into mania or cycle acceleration. Acta Psychiatr Scand 2008;118:337-346.
16. GRUNZE H, VIETA E, GOODWIN GM et al. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2010 on the treatment of acute bipolar depression. World J Biol Psychiatry 2010;11:81-109.
17. BALDESSARINI RJ, LEAHY L, ARCONA S, GAUSE D, ZHANG W, HENNEN J. Patterns of psychotropic drug prescription for U.S. patients with diagnoses of bipolar disorders. Psychiatr Serv 2007;58:85-91.
18. GREIL W, HABERLE A, HAUEIS P, GROHMANN R, RUSSMANN S. Pharmacotherapeutic trends in 2231 psychiatric inpatients with bipolar depression from the International AMSP Project between 1994 and 2009. J Affect Disord 2012;136:534-542.
19. BAEK JH, HA K, YATHAM LN et al. Pattern of pharmacotherapy by episode types for patients with bipolar disorders and its concordance with treatment guidelines. J Clin Psychopharmacol 2014;34:577-587.
20. THYGESEN LC, DAASNES C, THAULOW I, BRONNUM-HANSEN H. Introduction to Danish (nationwide) registers on health and social issues: structure, access, legislation, and archiving. Scand J Public Health 2011;39(Suppl. 7):12-16.
21. PEDERSEN CB, GOTZSCHE H, MOLLER JO, MORTENSEN PB. The Danish civil registration system. A cohort of eight million persons. Dan Med Bull 2006;53:441-449.
22. MORS O, PERTO GP, MORTENSEN PB. The Danish psychiatric central research register. Scand J Public Health 2011;39(Suppl. 7):54-57.
23. World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders. Diagnostic Criteria for Research, Geneva. 1993.
24. KILDEMOES HW, SORENSEN HT, HALLAS J. The Danish national prescription registry. Scand J Public Health 2011;39(Suppl. 7):38-41.
25. MEDICI CR, VIDEBECH P, GUSTAFSSON LN, MUNK-JORGENSEN P. Mortality and secular trend in the incidence of bipolar disorder. J Affect Disord 2015;183:39-44.
26. KRISTIANSEN CB, SHANMUGANATHAN JW, GUSTAFSSON LN, LOKKE KP, MUNK-JORGENSEN P. Increasing incidence and diagnostic instability in adult attention-deficit hyperactivity disorder nationwide between 1995 and 2012. Atten Defic Hyperact Disord 2015;7:151-156.
27. BALDESSARINI RJ, TONDO L, VAZQUEZ GH et al. Age at onset versus family history and clinical outcomes in 1,665 international bipolar-I disorder patients. World Psychiatry 2012;11:40-46.
28. GRANT BF, STINSON FS, HASIN DS et al. Prevalence, correlates, and comorbidity of bipolar I disorder and axis I and II disorders: results from the national epidemiologic survey on alcohol and related conditions. J Clin Psychiatry 2005;66:1205-1215.
29. GHAEMI SN, BOIMAN EE, GOODWIN FK. Diagnosing bipolar disorder and the effect of antidepressants: a naturalistic study. J Clin Psychiatry 2000;61:804-808. quiz 809.
30. OSTERGAARD SD, BERTELSEN A, NIELSEN J, MORS O, PETRIDES G. The association between psychotic mania, psychotic depression and mixed affective episodes among 14,529 patients with bipolar disorder. J Affect Disord 2013;147:44-50.
31. BERK M, DODD S, CALLALY P et al. History of illness prior to a diagnosis of bipolar disorder or schizoaffective disorder. J Affect Disord 2007;103:181-186.
32. PEDERSEN CB, MORS O, BERTELSEN A et al. A comprehensive nationwide study of the incidence rate and lifetime risk for treated mental disorders. JAMA Psychiatry 2014;71:573-581.
33. KROON JS, WOHLFARTH TD, DIELEMAN J et al. Incidence rates and risk factors of bipolar disorder in the general population: a population-based cohort study. Bipolar Disord 2013;15:306-313.
34. RUSSO P, SMITH MW, DIRANI R, NAMJOSHI M, TOHEN M. Pharmacotherapy patterns in the treatment of bipolar disorder. Bipolar Disord 2002;4:366-377.
35. HARDOON S, HAYES JF, BLACKBURN R et al. Recording of severe mental illness in United Kingdom primary care, 2000-2010. PLoS One 2013;8:e82365.
36. DIFLORIO A, JONES I. Is sex important? Gender differences in bipolar disorder. Int Rev Psychiatry 2010;22:437-452.
37. GRUNZE H, VIETA E, GOODWIN GM et al. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania. World J Biol Psychiatry 2009;10:85-116.
38. NIERENBERG AA, OSTERGAARD SD, IOVIENO N, WALKER RS, FAVA M, PAPAKOSTAS GI. Predictors of placebo response in bipolar depression. Int Clin Psychopharmacol 2015;30:59-66.
39. POST RM, KETTER TA, PAZZAGLIA PJ et al. Rational polypharmacy in the bipolar affective disorders. Epilepsy Res Suppl 1996;11:153-180.
40. MUNK-JORGENSEN P, OSTERGAARD SD. Register-based studies of mental disorders. Scand J Public Health 2011;39(Suppl. 7):170-174.
41. BOCK C, BUKH JD, VINBERG M, GETHER U, KESSING LV. Validity of the diagnosis of a single depressive episode in a case register. Clin Pract Epidemiol Ment Health 2009;5:1-8.
42. KESSING L. Validity of diagnoses and other clinical register data in patients with affective disorder. Eur Psychiatry 1998;13:392-398.
43. UGGERBY P, OSTERGAARD SD, ROGE R, CORRELL CU, NIELSEN J. The validity of the schizophrenia diagnosis in the Danish psychiatric central research register is good. Dan Med J 2013;60:A4578.
44. OLIVEROS JC. An interactive tool for comparing lists with Venn's diagrams. Available at http://bioinfogp.cnb.csic.es/tools/venny/index.html. Accessed August 2015.